|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Revenue | |||
| Cost of sales | |||
| Gross (loss)/profit | |||
| Research and development expenses | |||
| General administrative expenses | |||
| Foreign exchange (losses)/gains | |||
| Loss on forward contracts | |||
| Other income | |||
| Operating loss | |||
| Finance income | |||
| Finance expenses | |||
| Share of loss of joint venture | |||
| Loss before taxation | |||
| Income tax benefit | |||
| Loss for the year | |||
| Other comprehensive (loss)/income: | |||
| Items that may be reclassified to profit or loss | |||
| Foreign currency (loss)/gain on translation of foreign operations | |||
| Items that will not be reclassified to profit or loss | |||
| Change in fair value of financial assets at fair value through OCI | |||
| Total other comprehensive (loss)/income for the year, net of tax | |||
| Total comprehensive loss for the year | |||
| Basic loss per share (GBP per share) | |||
| Diluted loss per share (GBP per share) |
Loading...
